Abstract
The sex steroid hormone, estrogen, has been proposed to be protective against schizophrenia. This study examined the effects of estrogen treatment on modulation of prepulse inhibition (PPI) by the serotonin-1A (5-HT1A) receptor partial agonist, buspirone. PPI is a model of sensorimotor gating, which is deficient in schizophrenia and other mental illnesses. A total of 11 healthy women were tested following four acute treatment conditions: placebo, buspirone (Buspar; 5 mg), estradiol (Estrofem; 2 mg), and combined buspirone and estradiol. Electromyogram activity was measured across three interstimulus intervals (ISI): 30, 60, and 120 ms. There was no significant effect of either drug treatment on startle amplitude or habituation. At 120 ms ISI, buspirone caused a significant disruption of PPI and pretreatment with estrogen prevented this disruption. Estrogen treatment, administered in the appropriate experimental conditions, prevented PPI deficits induced by 5-HT1A receptor activation and may therefore also play a protective role in sensorimotor gating deficits in schizophrenia.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Anokhin AP, Heath AC, Myers E, Ralano A, Wood S (2003). Genetic influences on prepulse inhibition of startle reflex in humans. Neurosci Lett 353: 45–48.
Bantick RA, Deakin JF, Grasby PM (2001). The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15: 37–46.
Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234–258.
Burnet PW, Eastwood SL, Harrison PJ (1997). [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30: 565–574.
Cadenhead KS, Geyer MA, Braff DL (1993). Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150: 1862–1867.
Canuso CM, Goldstein JM, Green AI (1998). The evaluation of women with schizophrenia. Psychopharmacol Bull 34: 271–277.
Filion DL, Dawson ME, Schell AM (1993). Modification of the acoustic startle-reflex eyeblink: a tool for investigating early and late attentional processes. Biol Psychol 35: 185–200.
Fink BJ, Christensen MS (1981). Bioavailability of oestradiol and oestriol administered orally to oophorectomized women. Maturitas 3: 289–294.
Flugge G, Pfender D, Rudolph S, Jarry H, Fuchs E (1999). 5HT1A -receptor binding in the brain of cyclic and ovariectomized female rats. J Neuroendocrinol 11: 243–249.
Furuhjelm M, Karlgren E, Carlstrom K (1984). The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand 63: 655–661.
Ganong WF (1979). Review of Medical Physiology. Lange Medical Publications: CA, USA. pp 340–350.
Gogos A, Van den Buuse M (2003). Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behav Neurosci 117: 1407–1415.
Gogos A, Van den Buuse M (2004). Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309: 267–274.
Häfner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W (1993). Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23: 925–940.
Hellewell JS, Guimaraes FS, Wang M, Deakin JF (1999). Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans. J Psychopharmacol 13: 122–127.
Jackson A, Etgen AM (2001). Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT. Pharmacol Biochem Behav 68: 221–227.
Johansson C, Jackson DM, Zhang J, Svensson L (1995). Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol Biochem Behav 52: 649–654.
Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A et al (2004). Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41: 401–406.
Kodsi MH, Swerdlow NR (1994). Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Res 643: 59–65.
Kulkarni J, Riedel A, de Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J et al (2001). Estrogen—a potential treatment for schizophrenia. Schizophr Res 48: 137–144.
Kumari V, Aasen I, Sharma T (2004). Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr Res 69: 219–235.
Kumari V, Soni W, Mathew VM, Sharma T (2000). Prepulse inhibition of the startle response in men with schizophrenia. Arch Gen Psychiatry 57: 609–614.
Landry M, Di Paolo T (2003). Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Mol Brain Res 112: 82–89.
Lechin F, van der Dijs B, Jara H, Orozco B, Baez S, Benaim M et al (1998). Effects of buspirone on plasma neurotransmitters in healthy subjects. J Neural Transm 105: 561–573.
Mize AL, Alper RH (2000). Acute and long-term effects of 17beta-estradiol on G(i/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding. Brain Res 859: 326–333.
Mize AL, Poisner AM, Alper RH (2001). Estrogens act in rat hippocampus and frontal cortex to produce rapid, receptor-mediated decreases in serotonin 5-HT(1A) receptor function. Neuroendocrinology 73: 166–174.
Mizuki Y, Suetsugi M, Ushijima I, Yamada M (1994). Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Methods Find Exp Clin Pharmacol 16: 291–300.
Okazawa H, Yamane F, Blier P, Diksic M (1999). Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain. J Neurochem 72: 2022–2031.
Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R et al (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47: 662–669.
Phillips MA, Oxtoby EK, Langley RW, Bradshaw CM, Szabadi E (2000). Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 14: 258–265.
Rigdon GC, Weatherspoon JK (1992). 5-Hydroxytryptamine1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263: 486–493.
Seeman MV, Lang M (1990). The role of estrogens in schizophrenia gender differences. Schizophr Bull 16: 185–194.
Simpson MD, Lubman DI, Slater P, Deakin JF (1996). Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia. Biol Psychiatry 39: 919–928.
Sipes TA, Geyer MA (1995). 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology (Berl) 117: 41–48.
Sipos ML, Bauman RA, Widholm JJ, Kant GJ (2000). Behavioral effects of 8-OH-DPAT in chronically stressed male and female rats. Pharmacol Biochem Behav 66: 403–411.
Swerdlow NR, Hartman PL, Auerbach PP (1997). Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 41: 452–460.
Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001). Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl) 158: 230–240.
VanderMaelen CP, Matheson GK, Wilderman RC, Patterson LA (1986). Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol 129: 123–130.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gogos, A., Nathan, P., Guille, V. et al. Estrogen Prevents 5-HT1A Receptor-Induced Disruptions of Prepulse Inhibition in Healthy Women. Neuropsychopharmacol 31, 885–889 (2006). https://doi.org/10.1038/sj.npp.1300933
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300933
Keywords
This article is cited by
-
Neonatal phencyclidine as a model of sex-biased schizophrenia symptomatology in adolescent mice
Psychopharmacology (2023)
-
Sex and the Estrous-Cycle Phase Influence the Expression of G Protein-Coupled Estrogen Receptor 1 (GPER) in Schizophrenia: Translational Evidence for a New Target
Molecular Neurobiology (2023)
-
Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice
Psychopharmacology (2020)
-
Startling Differences: Using the Acoustic Startle Response to Study Sex Differences and Neurosteroids in Affective Disorders
Current Psychiatry Reports (2018)
-
Effects of selective estrogen receptor alpha and beta modulators on prepulse inhibition in male mice
Psychopharmacology (2015)
